{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:07:39Z","timestamp":1783548459150,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.4158\/ep-2019-0502","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T15:51:57Z","timestamp":1586965917000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Nasal Glucagon Delivery is More Successful than Injectable Delivery: A Simulated Severe Hypoglycemia Rescue"],"prefix":"10.1016","volume":"26","author":[{"given":"Julie A.","family":"Settles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg Francis","family":"Gerety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Spaepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Gideon","family":"Suico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Child","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0502_bb0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1753-0407.12933","article-title":"Hypoglycemia in diabetes: the dark side of diabetes treatment. A patient-centered review","volume":"11","author":"Johnson-Rabbett","year":"2019","journal-title":"J Diabetes"},{"key":"10.4158\/EP-2019-0502_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0145721707312400","article-title":"Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized","volume":"34","author":"Pearson","year":"2008","journal-title":"Diabetes Educ"},{"issue":"suppl 27","key":"10.4158\/EP-2019-0502_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/pedi.12698","article-title":"ISPAD clinical practice consensus guidelines 2018: assessment and management of hypoglycemia in children and adolescents with diabetes","volume":"19","author":"Abraham","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"suppl 1","key":"10.4158\/EP-2019-0502_bb0025","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.2337\/dc20-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes - 2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0502_bb0030","unstructured":"GlucaGen\u00ae HypoKit\u00ae prescribing informationAvailable at: https:\/\/www.novo-pi.com\/glucagenhypokit.pdf. Accessed June 1, 2019"},{"key":"10.4158\/EP-2019-0502_bb0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/cd18-0028","article-title":"Use of glucagon in patients with type 1 diabetes","volume":"37","author":"Haymond","year":"2019","journal-title":"Clin Diabetes"},{"key":"10.4158\/EP-2019-0502_bb0040","unstructured":"Baqsimi\u00ae (glucagon) nasal powder prescribing informationAvailable at: http:\/\/pi.lilly.com\/us\/baqsimi-uspi.pdf. Accessed August 1, 2019"},{"key":"10.4158\/EP-2019-0502_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/dc15-1498","article-title":"Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study","volume":"39","author":"Rickels","year":"2016","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0502_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00592-014-0665-0","article-title":"Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis with a comparison of glucagon with dextrose and of different glucagon formulations","volume":"52","author":"Boido","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.4158\/EP-2019-0502_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/dc15-1606","article-title":"Glucagon nasal powder: a promising alternative to intramuscular glucagon in youth with type 1 diabetes","volume":"39","author":"Sherr","year":"2016","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0502_bb0060","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bmj.287.6390.462-a","article-title":"Intranasal glucagon raises blood glucose concentrations in healthy volunteers","volume":"287","author":"Pontiroli","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.4158\/EP-2019-0502_bb0065","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/pedi.12668","volume":"19","author":"Deeb","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.4158\/EP-2019-0502_bb0070","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/dom.13278","article-title":"Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting","volume":"20","author":"Seaquist","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP-2019-0502_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pdi.1960140204","article-title":"IDDM patients' opinions on the use of glucagon emergency kit in severe episodes of hypoglycaemia","volume":"14","author":"Yanai","year":"1997","journal-title":"Practical Diabetes Int"},{"key":"10.4158\/EP-2019-0502_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/dia.2016.0460","article-title":"Faster use and fewer failures with needle-free nasal glucagon versus injectable glucagon in severe hypoglycemia rescue: a simulation study","volume":"19","author":"Yale","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.4158\/EP-2019-0502_bb0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3111\/13696998.2015.1006730","article-title":"Economic impact of severe and non-severe hypoglycemia in patients with type 1 and type 2 diabetes in the United States","volume":"18","author":"Foos","year":"2015","journal-title":"J Med Econ"},{"key":"10.4158\/EP-2019-0502_bb0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3111\/13696998.2011.610852","article-title":"Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs","volume":"14","author":"Fidler","year":"2011","journal-title":"J Med Econ"},{"key":"10.4158\/EP-2019-0502_bb0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/1932296819826577","article-title":"Nasal glucagon versus injectable glucagon for severe hypoglycemia: a cost-offset and budget impact analysis","volume":"13","author":"P\u00f6hlmann","year":"2019","journal-title":"J Diabetes Sci Technol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20350928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20350928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:21Z","timestamp":1761516501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20350928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1530891X20350928"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0502","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal Glucagon Delivery is More Successful than Injectable Delivery: A Simulated Severe Hypoglycemia Rescue","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}